Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
2017 ESC Report
European Society of Cardiology (ESC) Annual Congress Report From Barcelona 2017
Kimio SatohJun TakahashiYasuharu MatsumotoShunsuke TatebeTatsuo AokiYoku KikuchiKiyotaka HaoKazuma OhyamaMasamichi NogiAkira SudaShintaro KasaharaKoichi SatoSadamitsu IchijoHiroaki Shimokawa
Author information
JOURNAL FREE ACCESS FULL-TEXT HTML

2017 Volume 81 Issue 12 Pages 1758-1763

Details
Abstract

From August 26th to 30th, the 2017 Annual Congress of the European Society of Cardiology (ESC 2017) was held in Barcelona, Spain. Despite the terrorism tradegy just before the ESC congress, the congress attracted many medical professionals from all over the world to discuss the recent topics in cardiovascular medicine in more than 500 sessions, including COMPASS (Cardiovascular OutcoMes for People using Anticoagulation StrategieS Trial), CANTOS (Canakinumab Anti-Inflammatory Thrombosis Outcomes Study), and ORION (which assessed the effect of a novel siRNA inhibitor to PCSK9 on reductions in low-density lipoprotein cholesterol). Japanese cardiologists and the Japanese Circulation Society greatly contributed to the congress. This report briefly introduces some late-breaking registry results, late-breaking clinical trials, and ESC Guidelines from the ESC 2017 Congress.

Content from these authors
© 2017 THE JAPANESE CIRCULATION SOCIETY
Previous article Next article
feedback
Top